Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

Institutional Development Award (IDeA) for Clinical & Translational Research (CTR)

The Institutional Development Award program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Clinical & Translational Research (CTR) Notice of Funding Opportunity supports two programmatic tracks to build clinical and translational research capacity to enable research on diseases and health challenges prevalent in IDeA states. IDeA Clinical and Translational Research Development (CTR-D) awards focus on clinical and translational research workforce development and infrastructure enhancement at health research organizations in IDeA states that have limited clinical research capacity . IDeA Clinical & Translational Research Network (CTR-N) awards support statewide or multi-state networks of health research organizations to expand existing infrastructure, develop the research workforce to enhance the network organization’s ability to design and implement competitive clinical and translational research programs, and coordinate clinical research activities state-wide and/or across IDeA states.

Details

• Agency: National Institutes of Health
• Department: Department of Health and Human Services
• Opportunity #: PAR-26-030
• Instrument: grant

Eligibility

Eligibility is restricted to institutions that meet the following criteria:Are located in an IDeA-eligible state, commonwealth, or jurisdiction, which are Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming; andAward doctoral degrees in the health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies.